Department of Medicine

Investigators Hope to Build on Early Efficacy in KRAS G12C-Mutated CRC

Written by OncLive | April 14, 2022

Christopher Lieu, associate director for clinical research and codirector of gastrointestinal medical oncology at the University of Colorado Cancer Center, and an associate professor of medicine-medical oncology at the University of Colorado Medicine in Aurora, discussed new developments in CRC during the 7th Annual School of Gastrointestinal Oncology.